Status:
RECRUITING
The Study of Differences in Eosinophil Function and Subsets in Patients With Eosinophilic Pulmonary Diseases
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Eosinophil Subtype
Eosinophilic Pulmonary Diseases
Eligibility:
All Genders
18-90 years
Brief Summary
The study subjects of this research are patients with eosinophil-associated pulmonary diseases, including eosinophilic granulomatosis with polyangiitis, idiopathic hypereosinophilic syndrome, idiopath...
Eligibility Criteria
Inclusion
- For Healthy Volunteers: healthy volunteers matching the age and gender of the study subjects
- For EPD: ① Persistent eosinophil count increase\>1500 per cubic millimeter for more than 6 months. ② Lack of evidence of a secondary cause of eosinophilia is required. ③ Signs and symptoms of end-organ damage presumed to be secondary to eosinophilia
Exclusion
- Patients with concurrent definitive pulmonary infections, malignancies, or other parenchymal lung diseases;
- Patients who are unable or unwilling to cooperate with the collection of clinical information (e.g., due to mental disorders, memory impairments, etc.);
- Patients who are unable to provide informed consent.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06944418
Start Date
January 1 2024
End Date
January 1 2027
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730